Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes

被引：0
|
作者：
Feng-fei Li
Yun Shen
Rui Sun
Dan-feng Zhang
Xing Jin
Xiao-fang Zhai
Mao-yuan Chen
Xiao-fei Su
Jin-dan Wu
Lei Ye
Jian-hua Ma
机构：
[1] Nanjing Medical University,Department of Endocrinology, Nanjing First Hospital
[2] National Heart Research Institute Singapore,undefined
[3] National Heart Centre Singapore,undefined
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Glycemic variations; Insulin; Type 2 diabetes; Vildagliptin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1111 / 1122
页数：11
相关论文
共 50 条
  • [1] Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
    Li, Feng-fei
    Shen, Yun
    Sun, Rui
    Zhang, Dan-feng
    Jin, Xing
    Zhai, Xiao-fang
    Chen, Mao-yuan
    Su, Xiao-fei
    Wu, Jin-dan
    Ye, Lei
    Ma, Jian-hua
    [J]. DIABETES THERAPY, 2017, 8 (05) : 1111 - 1122
  • [2] EFFECTS OF METFORMIN OR ACARBOSE AS ADD-ON TO INSULIN THERAPY ON GLYCEMIC VARIABILITY IN TYPE 2 DIABETES
    Lu, J.
    Xiaojing, M.
    Lei, Z.
    Yifei, M.
    Lingwen, Y.
    Wei, L.
    Wei, Z.
    Yuqian, B.
    Jian, Z.
    Weiping, J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A61 - A62
  • [3] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    [J]. DIABETES, 2006, 55 : A111 - A111
  • [4] IMPROVED GLYCEMIC CONTROL WITH INSULIN GLARGINE VERSUS PIOGLITAZONE AS ADD-ON THERAPY TO SULFONYLUREA OR METFORMIN IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES MELLITUS
    Meneghini, Luigi F.
    Traylor, Louise
    Schwartz, Sherwyn L.
    [J]. ENDOCRINE PRACTICE, 2010, 16 (04) : 588 - 599
  • [5] Long-term efficacy and safety of add-on therapy of vildagliptin in type 2 diabetes mellitus with insulin treatment
    Kanazawa, Ippei
    Tanaka, Ken-ichiro
    Notsu, Masakazu
    Tanaka, Sayuri
    Kiyohara, Nobuaki
    Koike, Sayo
    Yamane, Yuko
    Tada, Yuko
    Sasaki, Motofumi
    Yamauchi, Mika
    Sugimoto, Toshitsugu
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S107 - S107
  • [6] Long-term efficacy and safety of vildagliptin add-on therapy in type 2 diabetes mellitus with insulin treatment
    Kanazawa, Ippei
    Tanaka, Ken-ichiro
    Notsu, Masakazu
    Tanaka, Sayuri
    Kiyohara, Nobuaki
    Koike, Sayo
    Yamane, Yuko
    Tada, Yuko
    Sasaki, Motofumi
    Yamauchi, Mika
    Sugimoto, Toshitsugu
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 123 : 9 - 17
  • [7] Vildagliptin as add-on therapy to insulin improves glycemic control without increasing risk of hypoglycemia in Asian, predominantly Chinese, patients with type 2 diabetes mellitus
    Ning, Guang
    Wang, Weiqing
    Li, Ling
    Ma, Jianhua
    Lv, Xiaofeng
    Yang, Ming
    Wang, Wei
    Woloschak, Michael
    Lukashevich, Valentina
    Kothny, Wolfgang
    [J]. JOURNAL OF DIABETES, 2016, 8 (03) : 345 - 353
  • [8] Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
    von Websky, Karoline
    Reichetzeder, Christoph
    Hocher, Berthold
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 681 - 694
  • [9] Vildagliptin as add-on therapy to other oral antidiabetics in Japanese patients with type 2 diabetes
    Suzuki, M.
    Hamada, I.
    Odawara, M.
    [J]. DIABETOLOGIA, 2012, 55 : S354 - S354
  • [10] Vildagliptin versus insulin as add-on therapy to glimepiride in type 2 diabetes mellitus: results from a randomised controlled trial
    Strotmann, H. -J.
    Goetze, D.
    Koch, C.
    Forst, T.
    [J]. DIABETOLOGIA, 2014, 57 : S364 - S365
12345